A carregar...
Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions
OBJECTIVE: To evaluate whether adverse event reports to the US Food and Drug Administration on incidents of ketoacidosis from use of sodium glucose cotransport inhibitors (SGLT2 inhibitors) provide insight into ways this new class of drugs is being prescribed with other antihyperglycemic agents; to...
Na minha lista:
| Publicado no: | Int J Nephrol Renovasc Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479258/ https://ncbi.nlm.nih.gov/pubmed/28670136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S135899 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|